As of 2026-09-07, the Fair Value of Maat Pharma SA (MAAT.PA) is -8.23 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.94 EUR, the upside of Maat Pharma SA is -380.09%.
With the market price of 2.94 EUR and our fair value calculation, Maat Pharma SA (MAAT.PA) is not a good investment. Investing in MAAT.PA stocks now will result in a potential loss of 380.09%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -9.02 | -13.71 | -19.72 | -28.91 | -31.06 | -20.48 |
| YoY growth | -70.14% | -52.05% | -43.78% | -46.60% | -7.46% | -44.00% |
| Market Cap (mil) | 55.45 |
| P/E | |
| Forward P/E |
| EPS | -1.65 |
| Avg earnings growth rate | -44.00% |
| TTM earnings | -31.06 |